408 related articles for article (PubMed ID: 33222247)
1. Organoids and Spheroids as Models for Studying Cholestatic Liver Injury and Cholangiocarcinoma.
Sato K; Zhang W; Safarikia S; Isidan A; Chen AM; Li P; Francis H; Kennedy L; Baiocchi L; Alvaro D; Glaser S; Ekser B; Alpini G
Hepatology; 2021 Jul; 74(1):491-502. PubMed ID: 33222247
[TBL] [Abstract][Full Text] [Related]
2. Patient-Derived Organoids from Human Bile: An In Vitro Method to Study Cholangiopathies.
Soroka CJ; Assis DN; Boyer JL
Methods Mol Biol; 2019; 1981():363-372. PubMed ID: 31016667
[TBL] [Abstract][Full Text] [Related]
3. A novel model of injured liver ductal organoids to investigate cholangiocyte apoptosis with relevance to biliary atresia.
Chusilp S; Lee C; Li B; Lee D; Yamoto M; Ganji N; Vejchapipat P; Pierro A
Pediatr Surg Int; 2020 Dec; 36(12):1471-1479. PubMed ID: 33084932
[TBL] [Abstract][Full Text] [Related]
4. Oncogenic KRAS-expressing organoids with biliary epithelial stem cell properties give rise to biliary tract cancer in mice.
Kasuga A; Semba T; Sato R; Nobusue H; Sugihara E; Takaishi H; Kanai T; Saya H; Arima Y
Cancer Sci; 2021 May; 112(5):1822-1838. PubMed ID: 33068050
[TBL] [Abstract][Full Text] [Related]
5. Generation of functional liver organoids on combining hepatocytes and cholangiocytes with hepatobiliary connections ex vivo.
Tanimizu N; Ichinohe N; Sasaki Y; Itoh T; Sudo R; Yamaguchi T; Katsuda T; Ninomiya T; Tokino T; Ochiya T; Miyajima A; Mitaka T
Nat Commun; 2021 Jun; 12(1):3390. PubMed ID: 34099675
[TBL] [Abstract][Full Text] [Related]
6. Induction of differentiation of intrahepatic cholangiocarcinoma cells to functional hepatocytes using an organoid culture system.
Saito Y; Nakaoka T; Muramatsu T; Ojima H; Sukeda A; Sugiyama Y; Uchida R; Furukawa R; Kitahara A; Sato T; Kanai Y; Saito H
Sci Rep; 2018 Feb; 8(1):2821. PubMed ID: 29434290
[TBL] [Abstract][Full Text] [Related]
7. [Establishment and application of intrahepatic cholangiocarcinoma organoid models].
Liu Y; Liang X
Zhonghua Wai Ke Za Zhi; 2024 Apr; 62(4):346-352. PubMed ID: 38432677
[TBL] [Abstract][Full Text] [Related]
8. Human primary liver cancer-derived organoid cultures for disease modeling and drug screening.
Broutier L; Mastrogiovanni G; Verstegen MM; Francies HE; Gavarró LM; Bradshaw CR; Allen GE; Arnes-Benito R; Sidorova O; Gaspersz MP; Georgakopoulos N; Koo BK; Dietmann S; Davies SE; Praseedom RK; Lieshout R; IJzermans JNM; Wigmore SJ; Saeb-Parsy K; Garnett MJ; van der Laan LJ; Huch M
Nat Med; 2017 Dec; 23(12):1424-1435. PubMed ID: 29131160
[TBL] [Abstract][Full Text] [Related]
9. An animal model of benign bile-duct stricture, sclerosing cholangitis and cholangiocarcinoma and the role of epidermal growth factor receptor in ductal proliferation.
Cheifetz RE; Davis NL; Owen DA
Can J Surg; 1996 Jun; 39(3):193-7. PubMed ID: 8640617
[TBL] [Abstract][Full Text] [Related]
10. Precancerous bile duct pathology in end-stage primary sclerosing cholangitis, with and without cholangiocarcinoma.
Lewis JT; Talwalkar JA; Rosen CB; Smyrk TC; Abraham SC
Am J Surg Pathol; 2010 Jan; 34(1):27-34. PubMed ID: 19898228
[TBL] [Abstract][Full Text] [Related]
11. Cholangiocytes in the pathogenesis of primary sclerosing cholangitis and development of cholangiocarcinoma.
Chung BK; Karlsen TH; Folseraas T
Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1390-1400. PubMed ID: 28844951
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis of cholangiocarcinoma in patients with PSC: a sight on cytology.
Baskin-Bey ES; Moreno Luna LE; Gores GJ
J Hepatol; 2006 Oct; 45(4):476-9. PubMed ID: 16901574
[No Abstract] [Full Text] [Related]
13. New insights on the molecular and cell biology of human cholangiopathies.
Alvaro D; Mancino MG
Mol Aspects Med; 2008; 29(1-2):50-7. PubMed ID: 18230407
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic benefit of biliary brush cytology in cholangiocarcinoma in primary sclerosing cholangitis.
Boberg KM; Jebsen P; Clausen OP; Foss A; Aabakken L; Schrumpf E
J Hepatol; 2006 Oct; 45(4):568-74. PubMed ID: 16879890
[TBL] [Abstract][Full Text] [Related]
15. Segmental cholangiectasia clinically worrisome for cholangiocarcinoma: comparison with recurrent pyogenic cholangitis.
Zhao L; Hosseini M; Wilcox R; Liu Q; Crook T; Taxy JB; Ferrell L; Hart J
Hum Pathol; 2015 Mar; 46(3):426-33. PubMed ID: 25600951
[TBL] [Abstract][Full Text] [Related]
16. Biliary dysplasia, cell proliferation and nuclear DNA-fragmentation in primary sclerosing cholangitis with and without cholangiocarcinoma.
Bergquist A; Glaumann H; Stål P; Wang GS; Broomé U
J Intern Med; 2001 Jan; 249(1):69-75. PubMed ID: 11168786
[TBL] [Abstract][Full Text] [Related]
17. Generation of Hepatic Organoids with Biliary Structures.
Katsuda T; Ochiya T; Sakai Y
Methods Mol Biol; 2019; 1905():175-185. PubMed ID: 30536100
[TBL] [Abstract][Full Text] [Related]
18. Genetic and epigenetic abnormalities in primary sclerosing cholangitis-associated cholangiocarcinoma.
Timmer MR; Beuers U; Fockens P; Ponsioen CY; Rauws EA; Wang KK; Krishnadath KK
Inflamm Bowel Dis; 2013 Jul; 19(8):1789-97. PubMed ID: 23615529
[TBL] [Abstract][Full Text] [Related]
19. Human Pluripotent Stem Cell-Derived Organoids as Models of Liver Disease.
Ramli MNB; Lim YS; Koe CT; Demircioglu D; Tng W; Gonzales KAU; Tan CP; Szczerbinska I; Liang H; Soe EL; Lu Z; Ariyachet C; Yu KM; Koh SH; Yaw LP; Jumat NHB; Lim JSY; Wright G; Shabbir A; Dan YY; Ng HH; Chan YS
Gastroenterology; 2020 Oct; 159(4):1471-1486.e12. PubMed ID: 32553762
[TBL] [Abstract][Full Text] [Related]
20. A case of intrahepatic cholangiocarcinoma associated with primary sclerosing cholangitis.
Kanemitsu E; Esaki M
Jpn J Clin Oncol; 2010 Jun; 40(6):600. PubMed ID: 20508074
[No Abstract] [Full Text] [Related]
[Next] [New Search]
